COBO Technologies will attend NIST Genome Editing Workshop in US

We are looking forward to meet all the members of the NIST - Genome Editing Consortium in US May 3rd. Our Co-founder and Scientific Advisor, Eric Paul Bennett and COO, Hasse Herlevsen will attend.

"Targeted genome editing technologies are being leveraged across many sectors including in the development of novel therapeutics. On Friday, May 3, 2019, NIST will host and convene a one-day public workshop with stakeholders across industry, academia, non-profit, and government to discuss industry-wide measurement challenges and potential standards solutions for genome editing technologies, particularly for the development of human therapeutic products. The outcomes of this workshop will inform participants on measurement challenges, technology advancements, and progress of the NIST Genome Editing Consortium on the path towards supporting and developing tools and solutions for genome editing in research and commercial products"

Tags

CIPP-IDAACorporate NewsCRISPRCRISPRQCGenome EditingInDel AnalysisNIST Genome Editing ConsortiumQuality Control Genome Editing